Skip to main content
An official website of the United States government


Placeholder slot

This page contains brief information about tremelimumab-actl and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

US Brand Name(s)
FDA Approved

FDA label information for this drug is available at DailyMed.

Use in Cancer

Tremelimumab-actl is approved to treat adults with:

Tremelimumab-actl is also being studied in the treatment of other types of cancer.

More About Tremelimumab-actl

Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.

Research Results and Related Resources

Study Identifies a Potential Cause of Immunotherapy’s Heart-Related Side Effects

Targeted Cancer Therapies

Immune Checkpoint Inhibitors

Monoclonal Antibodies

Clinical Trials Accepting Patients

Find Clinical Trials for Tremelimumab-actl - Check for trials from NCI's list of cancer clinical trials now accepting patients.

  • Posted:
  • Updated: